Knockdown of CCT2 was found to decrease the metastasis rate of breast cancer cells by inhibiting the activity and expression of MMP2/9, which act as matrix metalloproteases to degrade the extracellular matrix.83 This evidence concerns the gene CCT2 and breast cancer.